At the news
? NEUTRALIMPACT 2/10 144 filed Nov 13, 2026 at 15:53 ET
Officer Martin Wilson filed Form 144 notice to sell 4,087 shares of Rocket Pharmaceuticals, valued at approximately $9,197, with the sale intended to cover a tax obligation from a vested equity award distribution. The amount is trivial relative to the company's $272M market cap and Wilson's recent trading history, making this a routine administrative filing.
- Wilson Martin, an officer of Rocket Pharmaceuticals, filed Form 144 on 2026-11-13 to sell 4,087 shares of common stock.
- The proposed sale value is $9,196.98, based on an estimated price of $2.25 per share.
- The filing states the sale is to cover a tax obligation from the settlement of a vested equity award distribution.
- Wilson Martin has sold 133,877 shares in four transactions since August 2026, totaling approximately $398,238.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access